(42)To avoid overloading authorities and natural or legal persons with the work arising from the registration of phase-in substances already on the internal market, that registration should be spread over an appropriate period of time, without introducing undue delay. Deadlines for the registration of these substances should therefore be set.
◷
New version applies from 20/01/2009 — introduced by CLP Regulation.
111 provisions change.
Later versions: 20/02/2009, 27/06/2009, 02/04/2010, 01/12/2010, 21/02/2011, 06/03/2011, 05/05/2011, 10/12/2011, 01/06/2012, 05/06/2012, 09/10/2012, 06/03/2013, 21/04/2013, 01/07/2013, 10/04/2014, 22/08/2014, 01/01/2015, 23/03/2015, 13/05/2015, 01/06/2015, 25/09/2015, 27/12/2015, 03/02/2016, 08/03/2016, 01/04/2016, 21/06/2016, 14/07/2016, 11/10/2016, 02/01/2017, 02/03/2017, 04/07/2017, 10/10/2017, 31/01/2018, 01/03/2018, 09/05/2018, 01/12/2018, 07/01/2019, 02/07/2019, 30/10/2019, 01/01/2020, 27/02/2020, 28/04/2020, 24/08/2020, 01/01/2021, 15/02/2021, 05/07/2021, 25/08/2021, 01/10/2021, 08/01/2022, 01/03/2022, 01/05/2022, 14/10/2022, 17/12/2022, 28/05/2023, 29/06/2023, 06/08/2023, 01/12/2023, 06/06/2024, 10/10/2024, 22/04/2025, 23/06/2025, 01/09/2025, 23/10/2025, 11/05/2026, 22/06/2026.
Recital 42 changes in this version: compare with the current text.